References:
1. Ray MT, Shannon Weickert C, Webster MJ. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry 2014; 4 (5): e389.
2. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64 (6): 527–532.
3. Moliner R, Girych M, Brunello CA, et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci 2023; 26 (6): 1032–1041.
4. Ly C, Greb AC, Cameron LP, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep 2018; 23 (11): 3170–3182.
5. Olson DE. Biochemical mechanisms underlying psychedelic-induced neuroplasticity. Biochemistry 2022; 61 (3): 127–136.
6. Nutt D, Spriggs M, Erritzoe D. Psychedelics therapeutics: what we know, what we think, and what we need to research. Neuropharmacology 2023; 223: 109257.
